Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) SHH

29.22

-0.71(-2.37%)

Updated at January 14 03:00PM

Currency In CNY

Valuation

Market Cap4.29B
Enterprise Value4.35B
P/E Ratio184.49
PEG Ratio27.67
Price/Sales Ratio16.75
Price/Book Ratio12.34
Enterprise/Revenue17.07
Enterprise/EBITDA119.45

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.11

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue588.86M
Revenue/Share1.75
Gross Profit559.09M
EBITDA49.57M
Net Income20.76M
Diluted EPS0.05

Balance Sheet

Total Cash217.27M
Total Cash/Share0.54
Total Debt396.68M
Total Debt/Equity0.41
Current Ratio1.52
Book Value Per Share2.39

Price History

52-Week Change163.01
52-Week High34.68
52-Week Low10.7
Moving Average 50 Days25.39
Moving Average 200 Days22.11

Statistics

Average Volume5.92M
Shares Outstanding405.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.17
Last Split FactorN/A
Last Split DateN/A